Toft Group Executive Search, a global life sciences and healthcare executive recruiting firm, has successfully placed Linda Neuman, MD, MBA, as Vice President of Clinical Development with Catalyst Biosciences in South San Francisco, CA.
Dr. Neuman was previously with Adverum as Vice President of Clinical Development. Prior to Adverum she was the Vice President, Clinical Development for Sunesis Pharmaceuticals. Before then, she held the role of Senior Medical Director of Oncology at Puma Biotechnology. Dr. Neuman was Medical Director of Oncology at Onyx Pharmaceuticals where she served as clinical lead on the global product development team. Earlier in her industry career, Dr. Neuman held roles at Covidien Pharmaceuticals, Millennium Pharmaceuticals and Schering-Plough.
Dr. Neuman holds an MD from Southern Illinois University and an MBA from Indiana Wesleyan University.
About Catalyst Biosciences
Catalyst is a clinical-stage biopharmaceutical company developing novel medicines to address hematology indications. Catalyst is focused on the field of hemostasis, including the subcutaneous prophylaxis of hemophilia and facilitating surgery in individuals with hemophilia.
About Toft Group Executive Search
Toft Group is a global executive search firm fully devoted to life sciences and healthcare, with a focus on innovation-driven companies working at the intersection of biotech and high tech. The team’s extensive relationship network and diversity focus enables Toft Group to present more highly qualified and diverse candidates than clients would otherwise meet. Toft Group excels at quickly filling the hardest to hire leadership roles where talent is limited. The company has offices in the three major U.S. biotech hubs: San Francisco, San Diego, and Boston.